Fatality and interferon α for malignant melanoma
- 1 October 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9138) , 1443-1444
- https://doi.org/10.1016/s0140-6736(05)61266-4
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interferon alfa in malignant melanomaThe Lancet, 1997
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Clinical Toxicity of the InterferonsDrug Safety, 1994
- Recombinant alpha2 interferon-related cardiomyopathyThe American Journal of Medicine, 1988